Literature DB >> 26770491

Effect of dexmedetomidine on rats with renal ischemia-reperfusion injury and the expression of tight junction protein in kidney.

Yun-En Liu1, Chang-Ci Tong1, Yu-Biao Zhang1, Hong-Xu Jin1, Yan Gao1, Ming-Xiao Hou1.   

Abstract

To explore the protective effect of dexmedetomidine (Dex) on rats with renal ischemia-reperfusion injury and the influence of Dex on the expression of tight junction protein in kidney. Grouped 40 SPF male rats into 4 groups, sham operation group (group S), ischemia-reperfusion group (group I/R), pretreatment with Dex group (group Pre/Dex), post-treatment with Dex group (group Post/Dex), randomly, 10 rats each group. Rats in group S were anaesthetized and set up with removal of right kidney; rats in group I/R were set up with removal of right kidney and left renal artery clamping for 45 min followed by 60 min reperfusion; rats in group Pre/Dex were intravenous injected with Dex (1 μg/kg) for 30 min after indwelling catheter via femoral vein puncture; rats in group Post/Dex were intravenous injected with Dex (1 μg/kg) for 30 min after left renal reperfusion. The kidneys in each group were made out pathologic slices after 6 h I/R, stained with HE; blood samples were taken with separation plasma, creatinine (Scr) and urea nitrogen (BUN) were detected by automatic biochemical analyzer; IL-1β and TNF-α were detected by Enzyme-linked Immunosorbent Assay (ELISA); the expression level of tight junction protein ZO-1 and protein occludin in kidney were detected by Western-blot. The results of HE staining showed that, comparing to group S, the tissue of kidney in group I/R were damaged heavily with tubules dilatation and inflammation obviously, while lightened in group Pre/Dex and group Post/Dex. The results of detection of renal function and inflammatory factors showed that, comparing to group S, Scr, BUN, IL-1β and TNF-α were all enhanced in group I/R, group Pre/Dex and group Post/Dex, significantly (P < 0.05), while the inflammatory factors in group Pre/Dex and group Post/Dex were lower than in group I/R, significantly (P < 0.05). The results of Western-blot showed that the expression of protein ZO-1 and occludin in group Pre/Dex and group Post/Dex were higher than in group I/R, significantly (P < 0.05). Dex could reduce renal dysfunction induced by I/R, inhibit inflammatory response, up-regulate the expression of protein ZO-1 and occludin and protect renal.

Entities:  

Keywords:  Dexmedetomidine (Dex); ischemia-reperfusion; renal; renal function; tight junction protein

Year:  2015        PMID: 26770491      PMCID: PMC4694391     

Source DB:  PubMed          Journal:  Int J Clin Exp Med        ISSN: 1940-5901


  25 in total

1.  Comparison of propofol-dexmedetomidine, tiopental-dexmedetomidine and etomidate-dexmedetomidine combinations' effects on the tracheal intubation conditions without using muscle relaxants.

Authors:  K Bollucuoglu; V Hanci; S Yurtlu; D Okyay; H Ayoglu; I O Turan
Journal:  Bratisl Lek Listy       Date:  2013       Impact factor: 1.278

2.  Dexmedetomidine vs midazolam or propofol for sedation during prolonged mechanical ventilation: two randomized controlled trials.

Authors:  Stephan M Jakob; Esko Ruokonen; R Michael Grounds; Toni Sarapohja; Chris Garratt; Stuart J Pocock; J Raymond Bratty; Jukka Takala
Journal:  JAMA       Date:  2012-03-21       Impact factor: 56.272

Review 3.  Use of dexmedetomidine as a sedative and analgesic agent in critically ill adult patients: a meta-analysis.

Authors:  Jen A Tan; Kwok M Ho
Journal:  Intensive Care Med       Date:  2010-04-08       Impact factor: 17.440

4.  Acute preconditioning of cardiac progenitor cells with hydrogen peroxide enhances angiogenic pathways following ischemia-reperfusion injury.

Authors:  Karl D Pendergrass; Archana V Boopathy; Gokulakrishnan Seshadri; Kathryn Maiellaro-Rafferty; Pao Lin Che; Milton E Brown; Michael E Davis
Journal:  Stem Cells Dev       Date:  2013-05-25       Impact factor: 3.272

5.  Dexmedetomidine administration before, but not after, ischemia attenuates intestinal injury induced by intestinal ischemia-reperfusion in rats.

Authors:  Xu-Yu Zhang; Zi-Meng Liu; Shi-Hong Wen; Yun-Sheng Li; Yi Li; Xi Yao; Wen-Qi Huang; Ke-Xuan Liu
Journal:  Anesthesiology       Date:  2012-05       Impact factor: 7.892

6.  A synthetic peptide corresponding to the extracellular domain of occludin perturbs the tight junction permeability barrier.

Authors:  V Wong; B M Gumbiner
Journal:  J Cell Biol       Date:  1997-01-27       Impact factor: 10.539

7.  Structure-activity relationships of acetylcholine derivatives with Lucilia cuprina nicotinic acetylcholine receptor α1 and α2 subunits in chicken β2 subunit hybrid receptors in comparison with chicken nicotinic acetylcholine receptor α4/β2.

Authors:  H Dederer; M Berger; T Meyer; M Werr; T Ilg
Journal:  Insect Mol Biol       Date:  2013-01-21       Impact factor: 3.585

8.  Dexmedetomidine versus propofol for sedation in patients undergoing vitreoretinal surgery under sub-Tenon's anesthesia.

Authors:  Ashraf Ghali; Abdul Kader Mahfouz; Tapio Ihanamäki; Ashraf M El Btarny
Journal:  Saudi J Anaesth       Date:  2011-01

9.  Dexmedetomidine: A look at a promising new avenue of use.

Authors:  Thomas M Halaszynski
Journal:  Saudi J Anaesth       Date:  2012-04

Review 10.  The current role of endourologic management of renal transplantation complications.

Authors:  Brian D Duty; Michael J Conlin; Eugene F Fuchs; John M Barry
Journal:  Adv Urol       Date:  2013-08-19
View more
  7 in total

1.  Effects of perioperative dexmedetomidine infusion on renal function and microcirculation in kidney transplant recipients: a randomised controlled trial.

Authors:  Yin-Chin Wang; Ming-Jiuh Wang; Chih-Yuan Lee; Chien-Chia Chen; Ching-Tang Chiu; Anne Chao; Wing-Sum Chan; Meng-Kun Tsai; Yu-Chang Yeh
Journal:  Ann Med       Date:  2022-12       Impact factor: 5.348

Review 2.  Homeostasis of the Intraparenchymal-Blood Glutamate Concentration Gradient: Maintenance, Imbalance, and Regulation.

Authors:  Wei Bai; Yuan-Guo Zhou
Journal:  Front Mol Neurosci       Date:  2017-12-05       Impact factor: 5.639

3.  miR‑223‑3p/TIAL1 interaction is involved in the mechanisms associated with the neuroprotective effects of dexmedetomidine on hippocampal neuronal cells in vitro.

Authors:  Qi Wang; Hongmei Yu; Hong Yu; Meina Ma; Yali Ma; Rui Li
Journal:  Mol Med Rep       Date:  2018-12-11       Impact factor: 2.952

4.  Protective effect of dexmedetomidine on kidney injury of parturients with preeclampsia undergoing cesarean section: a randomized controlled study.

Authors:  Qing-Lin Zhang; Lei Wang; Ming-Jun Xu; Tian-Long Wang
Journal:  Biosci Rep       Date:  2019-05-03       Impact factor: 3.840

5.  Effects of dexmedetomidine on postoperative cognitive function of sleep deprivation rats based on changes in inflammatory response.

Authors:  Bin Guo; Chan Chen; Lin Yang; Rong Zhu
Journal:  Bioengineered       Date:  2021-12       Impact factor: 3.269

6.  An α2-adrenoceptor agonist: Dexmedetomidine induces protective cardiomyocyte hypertrophy through mitochondrial-AMPK pathway.

Authors:  Xiaojian Weng; Hua Liu; Xiaodan Zhang; Qianqian Sun; Cheng Li; Minglu Gu; Yanyifang Xu; Shitong Li; Weiwei Li; Jianer Du
Journal:  Int J Med Sci       Date:  2020-09-09       Impact factor: 3.738

Review 7.  Myocardial protective and anti-inflammatory effects of dexmedetomidine in patients undergoing cardiovascular surgery with cardiopulmonary bypass: a systematic review and meta-analysis.

Authors:  Milian Chen; Xia Li; Guo Mu
Journal:  J Anesth       Date:  2021-08-03       Impact factor: 2.931

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.